Covid-19 impact: Drugs essential, ancillaries not so, means supplies take a hit

National chemists and druggists association and industry lobby groups have urged the government to put all ancillary goods required for medicine production in the essential services category as they fear major supply disruptions in the days to come.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news